A reported event can match a listed reaction in kind and still be unexpected. ICH E2A: "Reports which add significant information on specificity or severity of a known, already documented serious ADR constitute unexpected events." Its examples:
- acute renal failure listed, a new report of interstitial nephritis (more specific);
- hepatitis listed, a first report of fulminant hepatitis (more severe).
21 CFR 314.80 gives the FDA's examples: hepatic necrosis is unexpected (greater severity) when the labeling only refers to raised hepatic enzymes or hepatitis; cerebral thromboembolism and cerebral vasculitis are unexpected (greater specificity) when the labeling only lists cerebral vascular accidents.
So the question is not only "is this event in the label?" but "is it in the label at this severity and specificity?" A serious reaction can still be expected when the label lists it as it happened, angioedema with a hospital stay, for example, when the label lists angioedema.